Supplementing with vitamin D did not alter the incidence of metabolic syndrome or increase insulin sensitivity or β cell activity in non-Western vitamin D-deficient immigrants with prediabetes. However, those who achieved a 25(OH)D concentration ≥60 nmol/L showed an improvement in the insulinogenic index when diabetes respondents were excluded. This evidence concerns the gene INS and prediabetes syndrome.